Summary
Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease characterized by optic nerve degeneration associated with severe bilateral visual loss in young men and occasionally in women. A mitochondrial DNA (mtDNA) replacement mutation in LHON patient, G to A transition at nucleotide position (nt) 11778 converting the 340th arginine to histidine in the NADH dehydrogenase subunit 4, was detected as SfaNI site polymorphism (Wallace et al., Science, 242: 1427 -1430 , 1988 . To evaluate if the SfaNI site loss can be used to diagnose LHON patients, mtDNAs from peripheral blood of six affected males including five probands from five unrelated Japanese families with LHON, a pair of parents and a normal sister of one of the probands and 4 control persons were analyzed using PCR amplification method. The mutation of leukocyte mtDNA at nt 11778 was identified in all of the affected patients, the normal mother and the sister examined, while the father who is normal and 4 control persons did not show the change. These findings support that the mutation at nt 11778 is also associated with LHON in the Japanese and the test of the SfaNI site loss described here is useful for confirming the clinical diagnosis of LHON patients with the mutation at nt 11778.
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mitochondrial DNA, Leber's hereditary optic neuropathy, maternal inheritance, point mutation, PCR INTRODUCTION Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease characterized by optic nerve degeneration associated with severe, bilateral visual loss in young men and occasionally in women. LHON patients have been found to be related exclusively through the maternal lineage (Imai and Moriwaki, 1936; Nikoskelainen et aI., 1987) . The human mitochondrial DNA (mtDNA) is also maternally inherited (Giles et al., 1980) . A mtDNA replacement mutation, G to A transition at nucleotide position (nt) 11778 converting the 340th arginine to histidine in the NADH dehydrogenase subunit 4, detected as a SfaNI site polymorphism, was identified in nine of 11 LH-ON families by Wallace et aI. (1988) . Arginine is highly conserved among various species, being present in identical positions in the proteins (Bibb et al., 1981; Anderson et al., 1982) . The same mutation detected as the SfaNI site polymorphism has been identified in Japanese LHON families (Yoneda et al., 1989 (Yoneda et al., , 1990 Hotta et al., 1989; Mashima et al., 1989) .
In the present study, to evaluate if the SfaNI site loss can be used to diagnose LHON patients, the mtDNAs from peripheral blood of six affected males including five probands from five unrelated Japanese families with LHON, a pair of parents and a sister of one of the probands, and 4 normal persons were analyzed using the polymerase chain reaction (PCR).
MATERIALS AND METHODS
The study was based on five Japanese families (families A-E) with LHON. In family A (Fig. 1) , an affected brother, a clinically normal sister and normal parents of the prcband were studied. In each of the other four families, only an affected proband was available for the examination, where the proband of family B has an affected brother and two affected maternal uncles; the proband of family C has an affected maternal grandmother's brother and maternal sister's son; the proband of family D has an affected brother and two affected nephews who are sister's sons of the proband; and family E has no effected person other than the proband. Four independent normal controls were also tested.
Leukocyte pellets of these members were isolated from 10 ml of peripheral bloc& The mtDNA was obtained from the pellets with the Hirt's method (Hirt, 1967) . A 24 met sense primer oligonucleotide with ATTCTCATCCAAACCCCC-TGAAGC, corresponding to the sequence between 11660 and 11683 bases, and a 24 mer antisense primer with GAGAACGTGGTTACTAGCACAGAG between 11896 and 11919 bases of mtDNA were prepared using a DNA synthesizer (Applied Biosystems, Foster city, CA). About 100 ng DNA was amplified by a DNA amplification system (Perkin Elmer Cetus, Emeryville, CA). After DNA purifica- (II-2) , the affected brother (II-1), the normal sister (II-3) and the mother (I-2). Likewise, the other four patients of the four unrelated families did not show the 130 bp fragments.
DISCUSSION
The nt 11778 mutation discovered by Wallace et al. (1988) was detected in all Vol. 36, No. 2, 1991 of the five families examined. Identical mutation has been found in other Japanese families (Yoneda et al., 1989 (Yoneda et al., , 1990 Mashima et al., 1989) . These findings may suggest that the nt 11778 mutation is highly prevalent in Japanese LHON, though more families should be tested. On the other hand, Holt et al. (1989) and Vilkki et al. (1989) reported that LHON is a genetically heterogeneous disorder and about 50~ of cases of definite LHON are due to the nt 11778 mutation. More cases need to be studied to determine this point. The mutation induced by common ancestor might have been preserved for a long time because the Japanese population had formed a closed society for geographical and social reasons. The detection of the nt 11778 mutation is very useful for the diagnosis of LHON especially in Japanese.
The normal mother and sister of proband have lost SfaNI site in family A. Although they are 55 and 24 years old and may develop the disease, they are at present only carriers. A strong male bias and the occasional appearance of symptoms in females cannot be explained by a single mtDNA defect alone. It seems that additional factors are involved in the expression of the mutant phenotype. Recently, a variable mixture of the mutant and wild-type mtDNA (heteroplasmy) was reported in LHON families (Holt et al., 1989; Lott et al., 1990) . The relative proportion of mutant and wild-type mtDNA may be correlated with the risk of developing LHON. Further study is required to clarify the mechanism of the disease. To check the SfaNI site loss, nevertheless, is useful to diagnose LHON with nt 11778 mutation, because clinical diagnosis of LHON is often difficult.
